Taiwan - Delayed Quote
TWD
Tanvex BioPharma, Inc. (6541.TW)
27.95
-0.55
(-1.93%)
At close: 1:30:07 PM GMT+8
Loading chart for 6541.TW
- Previous Close
28.50 - Open
29.25 - Bid 27.95 x --
- Ask 28.10 x --
- Day's Range
27.85 - 29.25 - 52 Week Range
27.85 - 65.50 - Volume
357,772 - Avg. Volume
392,426 - Market Cap (intraday)
7.407B - Beta (5Y Monthly) 0.23
- PE Ratio (TTM)
-- - EPS (TTM)
-5.59 - Earnings Date (est.) --
- Forward Dividend & Yield -- (0.00%)
- Ex-Dividend Date --
- 1y Target Est
--
Recent News
View MorePerformance Overview
Trailing total returns as of 11/2/2026, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .
YTD Return
6541.TW
49.18%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
55.09%
1-Year Return
6541.TW
50.18%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
59.10%
3-Year Return
6541.TW
59.90%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
173.95%
5-Year Return
6541.TW
80.43%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
163.21%
Earnings Trends
View MoreStatistics
View MoreValuation Measures
-
Market Cap
-
Enterprise Value
-
Trailing P/E
-
Forward P/E
-
PEG Ratio (current)
-
Price/Sales (ttm)
-
Price/Book (mrq)
-
Enterprise Value/Revenue
-
Enterprise Value/EBITDA
Financial Highlights
Profitability and Income Statement
-
Profit Margin
-222.84%
-
Return on Assets (ttm)
-12.28%
-
Return on Equity (ttm)
-29.78%
-
Revenue (ttm)
657.56M
-
Net Income Avi to Common (ttm)
-1.47B
-
Diluted EPS (ttm)
-5.59
Balance Sheet and Cash Flow
-
Total Cash (mrq)
592.56M
-
Total Debt/Equity (mrq)
41.96%
-
Levered Free Cash Flow (ttm)
-1.27B
